Effect of paroxetine in combination with the 5-HT1A antagonists, NAD-299 and LY 426965, on expression of the immediate early gene arc in the rat brain

Effect of paroxetine in combination with the 5-HT1A antagonists, NAD-299 and LY 426965, on expression of the immediate early gene arc in the rat brain

Detaylı Bibliyografya
Asıl Yazarlar:	Tordera, R, Gray, K, Sprakes, M, Pei, Q, Sharp, T
Materyal Türü:	Journal article
Baskı/Yayın Bilgisi:	2002

Benzer Materyaller

Effect of different 5-HT1A receptor antagonists in combination with paroxetine on expression of the immediate-early gene Arc in rat brain.
Yazar:: Tordera, R, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Glutamate receptor activation is involved in 5-HT2 agonist-induced Arc gene expression in the rat cortex.
Yazar:: Pei, Q, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Use of Arc expression as a molecular marker of increased postsynaptic 5-HT function after SSRI/5-HT1A receptor antagonist co-administration.
Yazar:: Castro, E, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

The 5-HT2 agonist DOI increases the expression of the immediate early genes arc, homer, c-fos and zif-268 in rat brain regions ex vivo
Yazar:: Tordera, R, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Antidepressant drug treatment induces Arc gene expression in the rat brain.
Yazar:: Pei, Q, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Effects of the 5-HT(4) receptor agonist RS67333 and paroxetine on hippocampal extracellular 5-HT levels.
Yazar:: Licht, C, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Brain 5-HT neurotransmission during paroxetine treatment.
Yazar:: Sargent, P, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Effect of chronic electroconvulsive shock and antidepressant drug treatment on VGlut1 mRNA expression in rat brain regions
Yazar:: Tordera, R, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study.
Yazar:: Gartside, SE, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Effect of paroxetine and nefazodone on 5-HT1A receptor sensitivity.
Yazar:: Sargent, P, ve diğerleri
Baskı/Yayın Bilgisi: (1997)

Pharmacokinetics of immediate and sustained-release formulations of paroxetine: Population pharmacokinetic approach to guide paroxetine personalized therapy in chinese psychotic patients
Yazar:: Xiao-lin Li, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortex.
Yazar:: Pei, Q, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortex.
Yazar:: Pei, Q, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

The Different Roles of 5-HT2 and 5-HT3 Receptors on Antinociceptive Effect of Paroxetine in Chemical Stimuli in Mice
Yazar:: Murat Kesim, ve diğerleri
Baskı/Yayın Bilgisi: (2005-01-01)

The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortex (vol 489, pg 179, 2004)
Yazar:: Pei, Q, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Effect of endogenous 5-HT on [C-11]MDL 100907 binding investigated in rat brain using PET
Yazar:: Hirani, E, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Erratum: The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortex (European Journal of Pharmacology (2004) 489 (179-185) DOI: 10.1016/j.ejphar.2004.03.002)
Yazar:: Pei, Q, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Fenfluramine evokes 5-HT2A receptor-mediated responses but does not displace [11C]MDL 100907: small animal PET and gene expression studies.
Yazar:: Hirani, E, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Paroxetine-induced galactorrhea
Yazar:: S. Petrykiv, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

Changes in Characteristics of the Specific Binding of [3H]LY-278584, a 5-HT3–Receptor Antagonist, on Differentiated NG108-15 Cells
Yazar:: Kayoko Matsushima, ve diğerleri
Baskı/Yayın Bilgisi: (2010-01-01)

Investigation of the SSRI augmentation properties of 5-HT(2) receptor antagonists using in vivo microdialysis.
Yazar:: Boothman, L, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Is paroxetine causing me nightmares?
Yazar:: Akansha Bhardwaj, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Paroxetine overdose during pregnancy
Yazar:: Selin Acar, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

Connecting Lyα and Ionizing Photon Escape in the Sunburst Arc
Yazar:: M. Riley Owens, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Inclusion Scenarios and Conformational Flexibility of the SSRI Paroxetine as Perceived from Polymorphism of β-Cyclodextrin–Paroxetine Complex
Yazar:: Thammarat Aree
Baskı/Yayın Bilgisi: (2022-01-01)

Paroxetine treatment and the prolactin response to sumatriptan.
Yazar:: Wing, Y, ve diğerleri
Baskı/Yayın Bilgisi: (1996)

Azologization of serotonin 5-HT3 receptor antagonists
Yazar:: Karin Rustler, ve diğerleri
Baskı/Yayın Bilgisi: (2019-03-01)

Effect of chronic electroconvulsive shock and antidepressant drugs on mRNA expression of AMPA receptor subunits in the rat brain
Yazar:: Pei, Q, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Evidence for increased expression of the vesicular glutamate transporter, VGLUT1, by a course of antidepressant treatment.
Yazar:: Tordera, R, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Evidence for increased expression of the vesicular glutamate transporter, VGLUT1, by a course of antidepressant treatment.
Yazar:: Tordera, R, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Simultaneous blockade of 5-HT1A/B receptors and 5-HT transporters results in acute increases in extracellular 5-HT in both rats and guinea pigs: in vivo characterization of the novel 5-HT1A/B receptor antagonist/5-HT transport inhibitor SB-649915-B.
Yazar:: Hughes, Z, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Efficacy of cognitive behavioral therapy with paroxetine and paroxetine only for social anxiety disorder: A behavioral, placebo-controlled study
Yazar:: Narendranath Samantray, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)

Del 299 al 436

Del 299 al 436
Baskı/Yayın Bilgisi: (1998-04-01)

Pharmacokinetics of Paroxetine Tablets in healthy Arabic Subjects
Yazar:: Jaafar Jaber Ibraheem Al-Tamimi
Baskı/Yayın Bilgisi: (2016-06-01)

Paroxetine Induced Akathisia: Necessity for Rational Use
Yazar:: Maryam Mousavi, ve diğerleri
Baskı/Yayın Bilgisi: (2019-07-01)

Euprolactinemic galactorrhea with paroxetine: Exploring the missing link
Yazar:: Shree Mishra, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)

Critical appraisal of paroxetine for the treatment of vasomotor symptoms
Yazar:: Carroll DG, ve diğerleri
Baskı/Yayın Bilgisi: (2015-06-01)

Randomized trial of paroxetine in end-stage COPD
Yazar:: Y. Lacasse, ve diğerleri
Baskı/Yayın Bilgisi: (2004-09-01)

Combination of valproate and paroxetine in mice exposed to picrotoxin
Yazar:: Kamal SM
Baskı/Yayın Bilgisi: (2012-05-01)